Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for improving the quality of follow-up rehabilitation care at Lázně Darkov, a.s. in Karviná, Czech Republic. The estimated value is CZK 1,950,000, with a completion deadline of December 14, 2026.
Scope Of Work: The contract involves the supply of medical technologies and devices for rehabilitation care at Lázně Darkov, including 2 combined devices for verticalization and proprioceptive stimulation, 1 device for wound healing support, 7 mechanical rehabilitation machines, 5 active-passive trainers, and 3 light therapy devices. The delivery includes transportation, installation, operator training per Czech law, a minimum 24-month warranty service (60 months for light therapy devices), and documentation in Czech. The project is divided into 6 parts, with detailed specifications in the tender documents.
Qualification Criterion: Bidders must provide relevant experience in supplying medical technologies, comply with technical requirements, and submit mandatory documents including registration in the relevant systems. A detailed proposal including compliance with the specifications outlined in the tender documents is required. Bidders must also adhere to the warranty service terms and provide documentation in Czech.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Medicinal Product of Atc Group J06ba02 with the Active Substance Immunoglobulins, Normal Human, for Intravascular Application | Czech Republic | 152654081 | 18 Dec 2026 |
| Skiagraphic X-Ray Equipment Including Full Service Provision | Czech Republic | 152653770 | 15 Dec 2026 |
| Medicinal Product of Atc Group L04ac21 with the Active Substance Bimekizumab | Czech Republic | 152653613 | 18 Dec 2026 |
| Medicinal Product of Atc Group N02cd07 with the Active Substance Atogepant | Czech Republic | 152653358 | 18 Dec 2026 |
| Medicinal Product of Atc Group L04ac24 with the Active Substance Mirikizumab | Czech Republic | 152647180 | 18 Dec 2026 |